Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype
- 28 October 2006
- journal article
- Published by Elsevier BV in Cancer Letters
- Vol. 242 (2), 168-179
- https://doi.org/10.1016/j.canlet.2005.11.008
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- 5-Fluorouracil: mechanisms of action and clinical strategiesNature Reviews Cancer, 2003
- Adjuvant therapy in colon cancer: current status and future directionsCancer Treatment Reviews, 2002
- Induction of thymidylate synthase as a 5-fluorouracil resistance mechanismBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancerCancer Treatment Reviews, 2002
- Establishment and characterization of 5-fluorouracil-resistant gastric cancer cellsCancer Letters, 2000
- Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerJournal of Clinical Oncology, 2000
- Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trialThe Lancet, 2000
- Resistance to 5-FluorouracilGeneral Pharmacology: The Vascular System, 1998
- Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitroBiochemical Pharmacology, 1997
- Immunohistochemical determination of thymidylate synthase in colorectal cancer—methodological studiesEuropean Journal Of Cancer, 1997